Table 2.
Comparison (total sample size N = 658)
| Utstein | CAHP | sCAHP | mCAHP | OHCA | CREST | C-GRApH | TTM | NULL-PLEASE | rCAST | MIRACLE2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of items for score determination | 8 | 7 | 6 | 6 | 5 | 5 | 5 | 10 | 9 | 5 | 7 |
| Number of patients with calculated score | 658 | 649 | 649 | 649 | 640 | 544 | 607 | 557 | 640 | 625 | 620 |
| Proportion of patients with score available as compared to full cohort | 100.0% | 98.6% | 98.6% | 98.6% | 97.3% | 82.6% | 92.2% | 84.6% | 97.3% | 94.9% | 94.2% |
| Median score, IQR | NA |
147 [111–175] |
132 [101–156] |
94 [73–110] |
28 [13–41] |
2 [1–3] |
2 [1–3] |
17 [12–20] |
5 [3–6] |
9 [6.5–12] |
4 [2–5] |
| AUROC (95% CI) |
0.79 [0.76–0.83] |
0.87 [0.84–0.90] |
0.85 [0.81–0.87] |
0.86 [0.83–0.89] |
0.84 [0.81–0.88] |
0.79 [0.75–0.83] |
0.76 [0.71–0.80] |
0.88 [0.86–0.91] |
0.81 [0.77–0.84] |
0.82 [0.78–0.85] |
0.85 [0.82–0.88] |
| Hosmer–Lemeshow | |||||||||||
| Absolute value | 5.48 | 11.03 | 4.83 | 7.63 | 11.92 | 8.84 | 4.43 | 12.14 | 3.84 | 9.28 | 16.64 |
| P-value | 0.70 | 0.19 | 0.77 | 0.47 | 0.15 | 0.26 | 0.48 | 0.14 | 0.87 | 0.32 | 0.03 |
|
Comparison versus Utstein Delta AUROC (95% CI) |
NA |
0.08 [0.07–0.08] |
0.05 [0.04–0.06] |
0.07 [0.06–0.07] |
0.05 [0.05–0.05] |
0 [0–0] |
− 0.03 [− 0.03 to 0.05] |
0.09 [0.08–0.10] |
0.01 [0.01–0.02] |
0.02 [0.02–0.03] |
0.06 [0.05–0.06] |
| P-value | < 0.0001 | < 0.001 | < 0.001 | < 0.001 | 0.28 | 0.03 | < 0.001 | 0.20 | 0.16 | < 0.001 | |
| Added AUROC per item | 0.09 | 0.12 | 0.14 | 0.14 | 0.17 | 0.16 | 0.15 | 0.08 | 0.09 | 0.16 | 0.12 |
NA: Not applicable. AUROC: Area under the ROC curve. IQR: interquartile range